These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 14511320

  • 1. Involvement of poly ADP ribosyl polymerase-1 in acute but not chronic zinc toxicity.
    Sheline CT, Wang H, Cai AL, Dawson VL, Choi DW.
    Eur J Neurosci; 2003 Sep; 18(6):1402-9. PubMed ID: 14511320
    [Abstract] [Full Text] [Related]

  • 2. The role of NADPH oxidase and neuronal nitric oxide synthase in zinc-induced poly(ADP-ribose) polymerase activation and cell death in cortical culture.
    Kim YH, Koh JY.
    Exp Neurol; 2002 Oct; 177(2):407-18. PubMed ID: 12429187
    [Abstract] [Full Text] [Related]

  • 3. Astrocytic poly(ADP-ribose) polymerase-1 activation leads to bioenergetic depletion and inhibition of glutamate uptake capacity.
    Tang KS, Suh SW, Alano CC, Shao Z, Hunt WT, Swanson RA, Anderson CM.
    Glia; 2010 Mar; 58(4):446-57. PubMed ID: 19795500
    [Abstract] [Full Text] [Related]

  • 4. Zinc inhibits astrocyte glutamate uptake by activation of poly(ADP-ribose) polymerase-1.
    Suh SW, Aoyama K, Alano CC, Anderson CM, Hamby AM, Swanson RA.
    Mol Med; 2007 Mar; 13(7-8):344-9. PubMed ID: 17728843
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia.
    Iwashita A, Tojo N, Matsuura S, Yamazaki S, Kamijo K, Ishida J, Yamamoto H, Hattori K, Matsuoka N, Mutoh S.
    J Pharmacol Exp Ther; 2004 Aug; 310(2):425-36. PubMed ID: 15075382
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Poly(ADP-Ribose) polymerase-1 in acute neuronal death and inflammation: a strategy for neuroprotection.
    Skaper SD.
    Ann N Y Acad Sci; 2003 May; 993():217-28; discussion 287-8. PubMed ID: 12853316
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase.
    Endres M, Wang ZQ, Namura S, Waeber C, Moskowitz MA.
    J Cereb Blood Flow Metab; 1997 Nov; 17(11):1143-51. PubMed ID: 9390645
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Group I metabotropic glutamate receptors stimulate the activity of poly(ADP-ribose) polymerase in mammalian mGlu1-transfected cells and in cortical cell cultures.
    Meli E, Baronti R, Pangallo M, Picca R, Moroni F, Pellegrini-Giampietro DE.
    Neuropharmacology; 2005 Nov; 49 Suppl 1():80-8. PubMed ID: 16023154
    [Abstract] [Full Text] [Related]

  • 14. Blockade of PARP activity attenuates poly(ADP-ribosyl)ation but offers only partial neuroprotection against NMDA-induced cell death in the rat retina.
    Goebel DJ, Winkler BS.
    J Neurochem; 2006 Sep; 98(6):1732-45. PubMed ID: 16903875
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. NAD+ repletion prevents PARP-1-induced glycolytic blockade and cell death in cultured mouse astrocytes.
    Ying W, Garnier P, Swanson RA.
    Biochem Biophys Res Commun; 2003 Sep 05; 308(4):809-13. PubMed ID: 12927790
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.